Search Results
Mar 18, 2026, 18:34 ET Kuehn Law Encourages Investors of CTO Realty Growth, Inc. to Contact Law Firm
Company used deceptive and unsustainable practices to artificially inflate its AFFO and overstate the true profitability of its Ashford Lane property; (iii) accordingly, CTO's business and/or financial prospects were overstated; and (iv) as a result, public statements were materially false and misleading
More news about: Kuehn Law, PLLC
Mar 18, 2026, 17:33 ET Robbins LLP Urges LAKE Stockholders to Contact the Firm for Information About the Class Action Against Lakeland Industries, Inc.
these businesses on Lakeland's financial results, as well as the overall strength and quality of Pacific Helmets' and Jolly's respective operations; (iii) Lakeland's business and financial results were significantly deteriorating because of, inter alia, tariff-related headwinds and timing, certification
More news about: Robbins LLP
Mar 18, 2026, 17:28 ET GIII Investor Alert: G-III Apparel Group Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Inflating Non-GAAP Earnings Figures: Levi & Korsinsky
G-III Apparel Group Guided GAAP EPS to $2.72-$2.82 -- GAAP EPS Came in at $1.51NEW YORK, March 18, 2026 /PRNewswire/ -- G-III Apparel Group (NASDAQ: GIII) shareholders lost approximately 11.4% of their investment
More news about: Levi & Korsinsky
Mar 18, 2026, 17:28 ET IMMP Investor Alert: Immutep Ltd. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Management Allegedly Misrepresented Trial Progress: Levi & Korsinsky
(NASDAQ: IMMP) who lost money are urged to act now. On January 30, 2026, Immutep filed a 6-K stating that completion of the futility analysis for its Phase III TACTI-004 trial was "on track for the first quarter of CY2026." On March 13, 2026, the Independent Data Monitoring Committee recommended halting the
More news about: Levi & Korsinsky
Mar 18, 2026, 17:23 ET Robbins LLP Urges SMR Stockholders to Contact the Firm for Information About the Class Action Against NuScale Power Corporation
of NuScale capital to an entity that lacked any significant prior experience owning, financing, or operating nuclear energy generation facilities; (iii) the purported experience and qualifications attributed to ENTRA1 by defendants during the class period in fact referred to the purported experience
More news about: Robbins LLP
Mar 18, 2026, 16:52 ET TAT Technologies Reports Fourth Quarter 2025 Results
and overhaul ("MRO") services for heat transfer components and OEM of heat transfer solutions through our subsidiary Limco Airepair Inc. ("Limco"); (iii) MRO services for aviation components through our subsidiary, Piedmont Aviation Component Services LLC ("Piedmont") (mainly Auxiliary Power Units ("APUs")
More news about: TAT Technologies Ltd
Mar 18, 2026, 16:30 ET TEN Holdings, Inc. Reports Full Year 2025 Financial Results
enterprise adoption, and leveraging strategic partnerships to drive operational efficiency and sustainable performance," said Randolph Wilson Jones III, Chief Executive Officer of TEN Holdings. "These initiatives position TEN Holdings to deliver long-term value for shareholders."A cornerstone
More news about: TEN Holdings, Inc.
Mar 18, 2026, 16:09 ET Wilentz, Goldman & Spitzer, P.A. Welcomes Alexander Hemsley III to the Firm
March 18, 2026 /PRNewswire/ -- Wilentz, Goldman & Spitzer, P.A. is pleased to announce that Alexander Hemsley III has joined the firm as a Shareholder in its Woodbridge office. Mr. Hemsley is a member of the firm's Business and Commercial Litigation team,
More news about: Wilentz, Goldman & Spitzer, P.A.
Mar 18, 2026, 16:05 ET Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026
release; (ii) Talphera's developmental product candidates may not be beneficial to patients or healthcare providers or be successfully commercialized; (iii) risks relating to Talphera's ability to obtain regulatory approvals for its developmental product candidates; (iv) risks related to the ability of Talphera
More news about: Talphera, Inc.
Mar 18, 2026, 15:38 ET Medal of Honor Recipients Recognize Americans for Service and Sacrifice
a powerful example of service above self and heroism in its purest form.2026 Single Act of Heroism Honoree –. John (Johnny) Wactor III of Summerville SC (Posthumous)In the early morning hours of May 25, 2024, in downtown Los Angeles, Johnny Wactor made the ultimate
More news about: Congressional Medal of Honor Society
Mar 18, 2026, 15:06 ET Bitmine Immersion Technologies (BMNR) 宣佈其以太幣 (ETH) 持有量達 459.6 萬枚代幣，加密資產及現金總持有額達 115 億美元
Bitmine 為美國第 105 大最活躍交易股票，日均成交額達 10 億美元（5 日平均）Bitmine 持續獲得頂級機構投資者支持，包括 ARK 的 Cathie Wood、MOZAYYX、Founders Fund、Bill Miller III、Pantera、Kraken、DCG、Galaxy Digital 以及個人投資者 Thomas "Tom" Lee，攜手支持 Bitmine 收購 5% 以太幣的目標拉斯維加斯2026年3月19日
More news about: Bitmine Immersion Technologies, Inc.
Mar 18, 2026, 15:06 ET A Bitmine Immersion Technologies (BMNR) anuncia que suas reservas de ETH atingiram 4,596 milhões de tokens, e que suas reservas totais em criptomoedas e dinheiro somam US$ 11,5 bilhões
A Bitmine continua recebendo apoio de investidores institucionais de peso, como Cathie Wood (ARK), MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital e o investidor Thomas "Tom" Lee, para ajudar a empresa a atingir a meta de 5% do ETHLAS
More news about: Bitmine Immersion Technologies, Inc.
Mar 18, 2026, 15:02 ET Rosen Law Firm Encourages Immutep Ltd. Investors to Inquire About Securities Class Action Investigation - IMMP
this about: On March 13, 2026, Immutep issued a press release "announcing that the Independent Data Monitoring Committee (IDMC) for the TACTI-004 Phase III study evaluating eftilagimod alfa ('efti') in patients in 1(st) line non-small cell lung cancer has recommended the discontinuation of the trial following
More news about: THE ROSEN LAW FIRM, P. A.
Mar 18, 2026, 15:02 ET Bitmine Immersion Technologies (BMNR) annuncia che le partecipazioni in ETH raggiungono i 4,596 milioni di token, e che le partecipazioni totali in criptovalute e contanti ammontano a 11,5 miliardi di dollari
continua a essere sostenuta da un gruppo di investitori istituzionali di prim'ordine tra cui Cathie Wood di ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital e l'investitore privato Thomas "Tom" Lee a sostegno dell'obiettivo di Bitmine di acquisire il 5% di ETH
More news about: Bitmine Immersion Technologies, Inc.
Mar 18, 2026, 14:57 ET Bitmine Immersion Technologies (BMNR) anuncia que sus tenencias de ETH alcanzan los 4,596 millones de tokens y sus tenencias totales en criptomonedas y efectivo ascienden a 11.500 millones de dólares
respaldo de un grupo de inversionistas institucionales de primer nivel, entre los que se encuentran Cathie Wood de ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital y el inversionista particular Thomas "Tom" Lee, con el fin de respaldar el objetivo de Bitmine de adquirir el 5
More news about: Bitmine Immersion Technologies, Inc.
Mar 18, 2026, 13:39 ET In HelloNation, Personal Injury Attorney Edward M. Graves III Explains When to Call a Car Accident Lawyer
time-sensitive. Deadlines apply, evidence can disappear, and small missteps early in the process can create major problems later. Many clients of Edward M. Graves III, according to the article, initially believed they could manage their insurance claims on their own. It was only weeks or months later—when facing unpaid
More news about: HelloNation
Mar 18, 2026, 13:24 ET NSBA/SBTC Victory as House Passes Bill to Restart SBIR/STTR
basis;Enhanced training for federal agencies' acquisition workforces on Phase III awarding;Suggested Phase III utilization by procurement center representatives;The creation of standardized model contracts for Phase I, II and III;Changes under TABA (Technical and Business Assistance) to
More news about: National Small Business Association
Mar 18, 2026, 12:19 ET QURE ALERT: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of "Distorted" Data
a primary control for AMT-130.Hidden Requirements: That uniQure downplayed the necessity of a sham-controlled surgery arm for Phase III—a requirement the FDA now claims was never waived.Timeline Deception: That defendants misled investors regarding the timing of a Biologics
More news about: Hagens Berman Sobol Shapiro LLP
Mar 18, 2026, 12:03 ET Synteq Digital Names Drew Jones Vice President of Sales to Lead Enterprise Growth
ASIC high-performance compute, data center hardware supply chains, and digital asset infrastructure. The company deploys hardware in Tier III+ certified facilities, operating its own caged infrastructure and multi-homed fiber network, delivering enterprise-grade reliability from hyperscale
More news about: Synteq Digital
Mar 18, 2026, 11:52 ET Droppers Market Size Worth $61.81 Million by 2032, Exclusive Report by Maximize Market Research
Material PlasticsPolyethylenePolypropyleneRubberGlass Type I GlassType II GlassType III GlassBy Dropper Size Up to 2 ml2 ml – 6 ml6 ml – 10 mlAbove 10 mlBy
More news about: Maximize Market Research Pvt. Ltd.
Mar 18, 2026, 11:29 ET Alpha Aesthetics Partners Announces Partnership with LexRx and Inject with Lex
equity firm that focuses on building industry-leading companies in the healthcare services sector. Founded by its Chairman and CEO Patrick J. Haynes III in 1986, Thurston Group has returned over $4 billion of invested capital in its 39-year history. Thurston has an extensive track record of partnering
More news about: Alpha Aesthetics Partners
Mar 18, 2026, 10:29 ET Strengthening Education and Workforce Training: Workcred and the National Accreditation Commission Are Teaming Up
on.""We're excited to partner with NAC in this way to strengthen quality assurance across workforce education and training programs," said Terry Vaughan III, Ph.D., associate executive director of research at Workcred. "As these programs play a growing role in workforce development, it is critical that
More news about: Workcred
Mar 18, 2026, 10:27 ET Kelun-Biotech to Present the Final OS Analysis of Sacituzumab Tirumotecan (Sac-TMT) from the OptiTROP-Lung03 Study
for marketing in lung cancer. As of today, Kelun-Biotech has initiated 9 registrational clinical studies in China. MSD is evaluating 17 ongoing Phase III global clinical studies of sac-TMT as a monotherapy or with pembrolizumab or other anti-cancer agents for several types of cancer. These studies are
More news about: Kelun-Biotech
Mar 18, 2026, 10:22 ET Ballistic Ventures to Take the Stage at RSA Conference 2026
CISOs Unchained IIIThursday, March 26 | 1:30 PM | YBCA TheaterBallistic's Venture Partner Phil Venables
More news about: Ballistic Ventures
Mar 18, 2026, 10:15 ET Significant U.S. Uranium Deposit Advances with Permitting Team NUCL, CCJ, UEC, SMR, and NXE as Uranium Demand Meets Domestic Supply Urgency
not limited to, (i) market risks; (ii) the outcome of any legal proceedings that may be instituted against Eagle related to its business combination; (iii) failure to realize the anticipated benefits of the business combination; (iv) the inability to maintain the listing of the Company's securities on Nasdaq
More news about: Equity Insider